Clinicians
Clinicians Home Consult Request Knowledge Base Education Catalog Centers Of Excellence
Individuals & Families
Guidance Knowledge Base Resources
Our Tools
Clozapine Dose Planner LAI Conversion Tool LAI Explorer
About Us
Contact

Search for:

∕
Knowledge Base (Clinicians)
∕
Substance Use Disorders

Tag: Substance Use Disorders

Knowledge Base (Clinicians)

124 result(s) found.

What is patient-centered care?
Employment of people with serious mental illness
If marijuana is legal, is it ok for patients with serious mental illness to use it?
What is the best antidepressant to use in children?
What does recovery mean for someone living with a serious mental health disorder?
Can effective peer support be provided for individuals with co-occurring mental health and substance use disorders?
Practice Guidelines for the Psychiatric Evaluation of Adults, Third Edition
The 2009 Schizophrenia PORT Psychosocial Treatment Recommendations and Summary Statements
Alcohol Misuse: Screening and Behavioral Counseling Interventions in Primary Care
Position Statement 33: Substance Use Disorders
What is the best practice for treatment of co-occurring disorders?
Medical Directors’ Recommendations on Trauma-informed Care for Persons with Serious Mental Illness
Substance Use Best Practice Tool Guide
What are the challenges of patients accepting medication assisted treatment (MAT) for their opiate use disorder?
Management of physical health conditions in adults with severe mental disorders
Issue Brief: Substance-Induced Psychosis in First Episode Programming
Issue Brief: Treating Affective Psychosis and Substance Use Disorders Within Coordinated Specialty Care
What are available practice guidelines for substance abuse disorder?
What should primary care providers know how to do if they are working in mental health setting?
Is there a healthcare model that can treat medical problems, mental health conditions and substance use disorders at the same time and place?
What’s the best way to deal with a young person who is struggling with BOTH a substance use disorder and a psychiatric illness?
How does opioid use disorder increase the risk of contracting Hepatitis C and HIV?
Is it possible to receive primary care inside an opiate treatment program?
How do you manage Substance Use Disorders (SUDs) when the patient is also exhibiting signs of non SUD psychiatric disorders such as depression, bipolar, psychosis, PTSD or ADHD?
How do you optimize the clinical management of persons opioid use disorders (OUD) and co-occurring psychiatric disorders who are actively using opioids and are experiencing significant pain?
How do primary care providers and mental health experts feel about opioid and benzodiazepines co-prescribing?
How are Opioid Use Disorders (OUD) related to non-OUD psychiatric disorders?
How to screen and assess SUD in adolescents?
What role do primary care providers play in the evaluation of problematic substance use?
In lethal opioid overdoses, how do you differentiate between suicide by overdose and “accidental” overdoses?
How can Community Behavioral Health Organizations (CBHOs) help improve access to MAT for opioid use disorders?
What are best practices for managing Pain in Individuals with Serious Illness and Comorbid Substance Use Disorder and what are the risks associated with it?
There is a known association between depression and pain but is there also a connection between bipolar disorder and pain?
How do I get insurance to cover mental health and substance use disorder treatment?
Decisions in Recovery: Treatment for Opioid Use Disorder
Substance Use Disorders
How does the collaborative care model improve treatment access for people with substance use disorders?
For patients on MAT, how can behavioral treatment protocols be effective in supporting recovery?
If patients with opioid use disorders are detoxified successfully, why should they take medications rather than remaining “completely abstinent”?
How should doctors and their patients decide on the most appropriate pharmacological treatment with opioid use disorder?
What are the implications of the SAMHSA final rule to increase the Buprenorphine patient limit to 275?
What can be done to address stigma in addictions?
What interventions address stigma in addictions?
How should urine drug testing be used in clinical practice?
Why should urine drug screening be done in clinical practice?
What are four things that can be done to address the opioid epidemic?
How can telepsychiatry be used to treat addictive disorders?
What is Smart Recovery and isn’t it the same as AA?
How can healthcare providers prevent acute pain from becoming chronic pain?
What support options are available for healthcare providers with substance use disorders?
What are the components of a self-management approach to chronic pain?
How can communities address the barriers for potential outpatient buprenorphine prescribers in order to encourage them to treat patients with opioid use disorder?
Long-Term Effects of Evidence-Based Supported Employment on Earnings and on SSI and SSDI Participation Among Individuals With Psychiatric Disabilities
Supported Employment: Keys to a Successful Facility
There’s More to Young Adult Unemployment Than Mental Health: What Else to Look For
Blueprint for Building Inter-Agency Collaboration through Strategic Planning: Supporting the Employment of Youth & Young Adults with Serious Mental Health Conditions
Making it Work: Vocational Peer Mentors for Emerging Adults with Serious Mental Health Conditions (2014)
First and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update
Interventions for Adult Offenders With Serious Mental Illness
Addressing Suicidal Thoughts and Behaviors in Substance Abuse Treatment: A Treatment Improvement Protocol (TIP) Series 50
Training Projects/Weight Management and Well-being
TIP 55: Behavioral Health Services for People Who Are Homeless
TIP 57: Trauma-Informed Care in Behavioral Health Services
Integrated Treatment for Co-Occurring Disorders Evidence-Based Practices (EBP) Kit
Transition Age Youth With Mental Health Challenges in the Juvenile Justice System (2013)
Mental Health Criminal Justice Diversion
Understanding Neurobiology of Psychological Trauma: Tips for Working with Transition-age Youth
Screening and Assessment of Co-occurring Disorders in the Justice System
Reducing Criminal Recidivism for Justice-Involved Persons with Mental Illness: Risk/Needs/Responsivity and Cognitive-Behavioral Interventions
What is the best way to assess cognitive functioning in individuals with serious mental illness (SMI) without using a long battery of neurocognitive tests?
Municipal Courts: An Effective Tool for Diverting People with Mental and Substance Use Disorders from the Criminal Justice System
Six Steps to Improve Your Drug Court Outcomes for Adults with Co-Occurring Disorders
Naloxone: Overview and Considerations for Drug Court Programs
Painting the Current Picture: A National Report on Drug Courts and Other Problem-Solving Courts in the United States
First Episode Psychosis Resources: Focus on Effective Treatment Options
Coexisting severe mental illness and substance misuse: community health and social care services
Risk Factors for Violence in Serious Mental Illness
Key Substance Use and Mental Health Indicators in the United States: Results from the 2017 National Survey on Drug Use and Health
What is the evidence for cannabinoids for the treatment of SMI and symptoms of SMI?
HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics
Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition)
What should I consider if a patient is taking an antipsychotic medication and abusing substances?
Adults with Behavioral Health Needs Under Correctional Supervision: A Shared Framework for Reducing Recidivism and Promoting Recovery
Clinical Guide for Integrated Dual Disorder Treatment (IDDT)
Practice Guidance for COVID-19
SAMHSA Resources and Information on Coronavirus (COVID-19)
What should clinicians know about prescribing (naltrexone) Vivitrol injections for patients with co-occuring alcohol use disorder?
Integrated Treatment of PTSD and Substance Use Disorders: Examination of Imaginal Exposure Length
How can I better understand mental illness and how to respond to someone experiencing a crisis?
Integrated Systems and Services for People with Co-Occurring Mental Health and Substance Use Conditions: What’s Known, What’s New, and What’s Now?
Developing a Behavioral Health Workforce Equipped to Serve Individuals with Co-Occurring Mental Health and Substance Use Disorders
Association of Housing First Implementation and Key Outcomes Among Homeless Persons With Problematic Substance Use
Is housing first effective for people with serious mental illness and co-occurring substance use issues?
What is Assertive Community Treatment (ACT) for people with severe mental illness?
Implementation Guide: Serious Mental Illness (SMI) and Co-Occurring Disorders (COD)
Implementation Guide: Integrated screening and longitudinal, strength-based assessment for individuals with serious mental illness (SMI) and co-occurring substance use
Implementation Guide: Stage-Matched Interventions for Individuals with Serious Mental Illness (SMI) and Co-Occurring Substance Use
Implementation Guide: Skill-Building Interventions for Individuals with Serious Mental Illness (SMI) and Co-Occurring Substance Use Disorders
Implementation Guide: Integrated Medications for Addiction Treatment (MAT) for Opioid Use Disorder (OUD) in a Serious Mental Illness (SMI) Service Setting
Many of the clients I am referred for assessment in the MH clinic have current or recent substance use. I have been taught that to make a diagnostic assessment, patients need to be substance free for at least thirty days. Yet to provide services, a MH diagnosis is necessary. What should I do?
My MH agency offers a dual diagnosis group, but most of my clients won’t go. How can I help them with their co-occurring substance use if they won’t attend group? Isn’t group treatment the treatment of choice for people with a substance use disorder (SUD)?
How do I help someone who can’t seem to stop using? I’ve been working with a client with SMI and SUD for 3 years. When I met him, he had very severe substance use, but over the years I’ve helped him get into various types of SUD treatment and he has had some periods of sobriety. He keeps telling me he wants to be sober, and he does okay for a while and then he slips. He seems to be a chronic relapser, and I don’t know how to help him.
How can I help clients who live in environments where there is active substance use all around, and who are unable or unwilling to relocate? My client with SMI and SUD lives with her parents in a neighborhood where there is a lot of active substance use. She keeps relapsing because people in the neighborhood offer her drugs, and she doesn’t know how to say “no.” I want to find her a sober living situation, but there is nothing available. How do I help her?
How do I help clients with psychotic illnesses who report that marijuana (or other substance) is “helpful” or “relaxing”? My client with schizophrenia smokes marijuana whenever he can get it. He says it “relaxes him.” I’m convinced it’s contributing to his continuing psychotic symptoms, and to the fact that his medication doesn’t seem to be effective. He agrees that “many people think marijuana is bad,” but he states: “I’m going to hear voices anyway, and the marijuana helps me to deal with them.” He seems to be in pre-contemplation, and I don’t know what to do.
In my clinic, I am referred SMI patients to initiate or continue psychotropic medications. It is common for patients to be referred who are actively using alcohol, marijuana, and sometimes other substances. What should I do?
How many individuals who have serious mental illness also have a substance use disorder?
Racial-Ethnic Disparities in Mental Health Care
Treatment Improvement Protocol (TIP) 26: Treating Substance Use Disorder in Older Adults
Are there treatment plans that can address both SMI and any substance use or co-occurring disorders at the same time?
Is it possible to help individuals who have SMI to quit smoking?
The Stigma of Addiction
Interventions for Substance Use Disorders in Adolescents
Tennessee Department of Mental Health & Substance Abuse Services: Office of Faith Based Initiatives
Engagement in Mental Health Services
The Basics on Substance Use and Serious Mental Illness: Tobacco and Nicotine Products
The Basics on Substance Use and Serious Mental Illness: Cannabis
The Basics on Substance Use and Serious Mental Illness: Opioids
The Basics on Substance Use and Serious Mental Illness: Benzodiazepines and Other Sedative Hypnotics
The Basics on Substance Use and Serious Mental Illness: Stimulants
The Basics on Substance Use and Serious Mental Illness: Alcohol
The Roles of Forensic Nursing in Caring for Individuals with Serious Mental Illness
What should clinicians know about Brixadi (Subutex)?
What should clinicians know about Vivitrol (Naltrexone)?
What should clinicians know about Sublocade (Suboxone)?

Administered by

About SMI Adviser

Mission Statement

Our mission is to advance the use of a person-centered approach to care that ensures people who have SMI find the treatment and support they need.

For clinicians, we offer access to education, data, and consultations so you can make evidence-based treatment decisions.

For patients, families, friends, people who have questions, or people who care for someone with SMI, we offer access to resources and answers from a national network of experts.

Grant Statement

Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.

Terms & Privacy
Copyright

Sitemap

Clinicians
Individuals & Families
About
Contact

SMI Adviser is committed to ensuring accessibility of its website to people with disabilities. If you have trouble accessing any of the website's resources, please call us at 202-559-3900 for assistance.

Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.

© 2025 American Psychiatric Association. All rights reserved.